Undiagnosed type 2 diabetes during pregnancy is associated with increased perinatal mortality: a large population-based cohort study in Ontario, Canada
- PMID: 31994233
- DOI: 10.1111/dme.14250
Undiagnosed type 2 diabetes during pregnancy is associated with increased perinatal mortality: a large population-based cohort study in Ontario, Canada
Abstract
Aim: To compare perinatal outcomes in women with undiagnosed diabetes with gestational diabetes alone, pre-existing diabetes and women without diabetes, and to identify risk factors which distinguish them from women with gestational diabetes alone.
Methods: This population-based cohort study included administrative data on all women who gave birth in Ontario, Canada, during 2002-2015. Maternal/neonatal outcomes were compared across groups using logistic regression, adjusting for confounders. A nested case control study compared women with undiagnosed type 2 diabetes with women with gestational diabetes alone to determine risk factors that would help identify these women.
Results: Among 995 990 women, 68 163 had gestational diabetes (6.8%) and, of those women with gestational diabetes,1772 had undiagnosed type 2 diabetes (2.6%). Those with undiagnosed type 2 diabetes were more likely to be older, from a lower income area, have parity > 3 and BMI ≥ 30 kg/m2 compared with gestational diabetes alone. Infants had a higher risk of perinatal mortality (OR 2.3 [1.6-3.4]), preterm birth (OR 2.6 [2.3-2.9]), congenital anomalies (OR 2.1 [1.7-2.5]), neonatal intensive care unit admission (OR 3.1 [2.8-3.5]) and neonatal hypoglycaemia (OR 406.0 [357-461]), which were similar to women with pre-existing diabetes. The strongest predictive risk factors included early gestational diabetes diagnosis, previous gestational diabetes and chronic hypertension.
Conclusions: Women diagnosed with gestational diabetes who develop diabetes within 1 year postpartum are at higher risk of adverse pregnancy outcomes, including perinatal mortality. This highlights the need for earlier diagnosis, preferably pre-pregnancy, and more aggressive treatment and surveillance of suspected type 2 diabetes during pregnancy.
© 2020 Diabetes UK.
References
-
- Feig DS, Hwee J, Shah BR, Booth GL, Bierman AS, Lipscombe LL. Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, population-based study in Ontario, Canada, 1996-2010. Diabetes Care 2014; 37: 1590-1596.
-
- Mackin ST, Nelson SM, Kerssens J, Wood R, Wild S, Colhoun HM et al. Diabetes and pregnancy: national trends over a 15 year period. Diabetologia 2018; 61: 1081-1088.
-
- Bardenheier BH, Imperatore G, Gilboa SM, Geiss LS, Saydah SH, Devlin HM et al. Trends in gestational diabetes among hospital deliveries in 19 U.S. states, 2000-2010. Am J Prev Med 2015; 49: 12-19.
-
- Balsells M, García-Patterson A, Gich I, Corcoy R. Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol Metab 2009; 94: 4284-4291.
-
- Bashir M, Dabbous Z, Baagar K, Elkhatib F, Ibrahim A, Brich S-A et al. Type 2 diabetes mellitus in pregnancy: the impact of maternal weight and early glycaemic control on outcomes. Eur J Obstet Gynecol 2019; 233: 53-57.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
